Abiopharma

IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

High Tides German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Ouster and AIM Intelligent Machines Announce Strategic Agreement for Digital Lidar to Equip AI-Powered Heavy Earthmoving Equipment Following the Release of REV8 with Native Color

Shareholder Alert: Ademi LLP investigates whether Huntsman Corporation is obtaining a Fair Price for Public Shareholders

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

Change - Announcement of Appointment: Appointment of Independent Non-Executive Director

Designated Market Maker (DMM) Obligations: Guotai Junan Investments (Hong Kong) Limited suspends quotation of ICBC CSOP FTSE CHN GOV BD ETF

General Announcement: Outcome of Legal Proceedings and Filing of Notice of Appeal by Wholly-Owned Subsidiary